A detailed history of Northwest Investment Counselors, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Northwest Investment Counselors, LLC holds 1,031 shares of ABBV stock, worth $171,104. This represents 0.05% of its overall portfolio holdings.

Number of Shares
1,031
Holding current value
$171,104
% of portfolio
0.05%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 12, 2024

BUY
$159.82 - $182.1 $164,774 - $187,745
1,031 New
1,031 $187,000
Q3 2023

Oct 12, 2023

BUY
$133.59 - $154.65 $90,707 - $105,007
679 Added 57.3%
1,864 $277,000
Q2 2023

Jul 11, 2023

SELL
$132.51 - $164.9 $18,153 - $22,591
-137 Reduced 10.36%
1,185 $159,000
Q1 2023

Apr 17, 2023

SELL
$144.61 - $166.54 $170,639 - $196,517
-1,180 Reduced 47.16%
1,322 $210,000
Q4 2022

Jan 18, 2023

SELL
$138.31 - $165.87 $565,272 - $677,910
-4,087 Reduced 62.03%
2,502 $0
Q3 2022

Oct 28, 2022

SELL
$134.21 - $153.93 $48,718 - $55,876
-363 Reduced 5.22%
6,589 $884,000
Q1 2022

Apr 18, 2022

SELL
$131.98 - $163.75 $120,761 - $149,831
-915 Reduced 11.63%
6,952 $1.13 Million
Q4 2021

Jan 26, 2022

SELL
$107.43 - $135.93 $139,659 - $176,709
-1,300 Reduced 14.18%
7,867 $1.07 Million
Q3 2021

Oct 19, 2021

BUY
$106.4 - $120.78 $91,504 - $103,870
860 Added 10.35%
9,167 $989,000
Q2 2021

Jul 22, 2021

BUY
$105.21 - $117.21 $15,991 - $17,815
152 Added 1.86%
8,307 $936,000
Q4 2020

Jan 26, 2021

BUY
$80.49 - $108.67 $12,556 - $16,952
156 Added 1.95%
8,155 $874,000
Q2 2020

Jul 14, 2020

BUY
$73.37 - $98.18 $10,345 - $13,843
141 Added 1.79%
7,999 $785,000
Q1 2020

Apr 21, 2020

SELL
$64.5 - $97.79 $19,350 - $29,337
-300 Reduced 3.68%
7,858 $599,000
Q3 2019

Oct 30, 2019

SELL
$62.98 - $75.72 $11,021 - $13,251
-175 Reduced 2.1%
8,158 $618,000
Q2 2019

Jul 25, 2019

SELL
$65.7 - $83.98 $4,861 - $6,214
-74 Reduced 0.88%
8,333 $606,000
Q1 2019

Apr 25, 2019

BUY
$77.14 - $90.79 $9,488 - $11,167
123 Added 1.48%
8,407 $678,000
Q4 2018

Jan 28, 2019

BUY
$77.85 - $96.01 $3,191 - $3,936
41 Added 0.5%
8,284 $764,000
Q3 2018

Oct 22, 2018

BUY
$88.91 - $98.84 $20,449 - $22,733
230 Added 2.87%
8,243 $780,000
Q2 2018

Jul 25, 2018

SELL
$89.78 - $106.23 $9,696 - $11,472
-108 Reduced 1.33%
8,013 $742,000
Q1 2018

Apr 13, 2018

SELL
$92.01 - $123.21 $32,847 - $43,985
-357 Reduced 4.21%
8,121 $769,000
Q4 2017

Feb 01, 2018

BUY
$89.56 - $98.21 $358 - $392
4 Added 0.05%
8,478 $820,000
Q3 2017

Oct 30, 2017

BUY
$69.85 - $89.22 $591,908 - $756,050
8,474
8,474 $753,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $293B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Northwest Investment Counselors, LLC Portfolio

Follow Northwest Investment Counselors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northwest Investment Counselors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Northwest Investment Counselors, LLC with notifications on news.